About Therapix Biosciences
Therapix Biosciences is a company based in Givatayim (Israel) founded in 2014 was acquired by FSD Pharma in October 2018.. Therapix Biosciences operates in a competitive market with competitors including Heron Therapeutics, Sanity Group, Relmada, ZYUS Life Sciences and Skye Bioscience, among others.
- Headquarter Givatayim, Israel
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$8.15 M (USD), Post-IPO
Mar 05, 2021
- Investors
-
Employee Count
Employee Count
-
Acquired by
FSD Pharma
(Oct 22, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Therapix Biosciences
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $8.2M
-
First Round
First Round
(02 Apr 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Post-IPO - Therapix Biosciences | Valuation |
investors |
|
| Jun, 2020 | Amount | Post-IPO - Therapix Biosciences | Valuation |
investors |
|
| Apr, 2019 | Amount | Post-IPO - Therapix Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Therapix Biosciences
Therapix Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Therapix Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Therapix Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Therapix Biosciences Comparisons
Competitors of Therapix Biosciences
Therapix Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heron Therapeutics, Sanity Group, Relmada, ZYUS Life Sciences and Skye Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Novel drug products for chronic pain treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| domain | founded_year | HQ Location |
Cannabinoid-based therapies for glaucoma and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Therapix Biosciences
Frequently Asked Questions about Therapix Biosciences
When was Therapix Biosciences founded?
Therapix Biosciences was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Where is Therapix Biosciences located?
Therapix Biosciences is headquartered in Givatayim, Israel. It is registered at Givatayim, Tel Aviv District, Israel.
Who is the current CEO of Therapix Biosciences?
Amitay Weiss is the current CEO of Therapix Biosciences.
What does Therapix Biosciences do?
Therapix Biosciences was founded in 2014 in Givatayim, Israel, within the biotechnology sector. Operations center on drug development for central nervous system disorders, utilizing an intellectual property portfolio of cannabinoid drugs and novel delivery systems. The pipeline features two programs: Brain Bright, a synthetic cannabinoid therapy for brain-related conditions, and a treatment for Tourette Syndrome based on the entourage effect, which has received orphan drug designation.
Who are the top competitors of Therapix Biosciences?
Therapix Biosciences's top competitors include Relmada, ZYUS Life Sciences and AlgoTx.
Who are Therapix Biosciences's investors?
Therapix Biosciences has 1 investor. Key investors include FSD Pharma.